Indication

Idiopathic macular telangiectasia type 2

Idiopathic macular telangiectasia type 2 is a chronic, bilateral, slowly progressive neurodegenerative disorder of the central retina that predominantly manifests in middle-aged and older adults. Read more about Idiopathic macular telangiectasia type 2

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Idiopathic macular telangiectasia type 2 therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Idiopathic macular telangiectasia type 2 preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Idiopathic macular telangiectasia type 2.

Idiopathic macular telangiectasia type 2 is a chronic, bilateral, slowly progressive neurodegenerative disorder of the central retina that predominantly manifests in middle-aged and older adults.

The pathophysiology involves the degeneration of retinal Müller glial cells and photoreceptors, accompanied by secondary vascular remodeling in the juxtafoveal region.

Characteristic clinical features include loss of retinal transparency, depletion of macular pigment, telangiectatic and ectatic capillary alterations that often exhibit late hyperfluorescent leakage, crystalline deposits, and cavitary changes with ellipsoid zone disruption on optical coherence tomography.

As the disease advances, patients experience progressive loss of central visual acuity, paracentral scotomas, and complications such as retinal pigment epithelium hyperplasia or subretinal neovascularization.

Personalize your experience

Follow Idiopathic macular telangiectasia type 2 and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it